PROM1 and melanoma: The results of this study demonstrated that inhibition of the Notch signaling pathway led to CD133-dependent mitogen-activated protein kinase (MAPK) signaling inhibition and eventually increased the interaction of tumor-associated endothelial cells and the migration of CD133+ cells, and blocked metastasis, melanoma growth, and angiogenesis.